Top Markets
Coin of the day
Epigenomics AG Epigenomics AG

Epigenomics AG

ECX
Classifica tra le azioni #38936
Founded in 1998 and headquartered in Berlin, Germany, Epigenomics AG is a... Founded in 1998 and headquartered in Berlin, Germany, Epigenomics AG is a molecular diagnostics company dedicated to the early detection of cancer through liquid biopsy methods. Its primary offering, Epi proColon, is a blood-based assay specifically developed for the early identification of colorectal cancer, distributed across the United States, Europe, and China. The company's portfolio further encompasses a blood test for hepatocellular carcinoma and Epi BiSKit, a pre-analytical solution providing reagents essential for preparing bisulfite-converted DNA. Epigenomics' research and development initiatives are focused on pinpointing relevant biomarkers in human tissue and subsequently creating and securing patents for associated in vitro diagnostic blood tests.
Prezzo delle azioni
$0.83030862
Ultima sincronizzazione: 2024-06-27
Capitalizzazione di mercato
$726.64K
Variazione (1 giorno)
-1.35%
Variazione (1 anno)
0.00%
Paese
DE
Scambia Epigenomics AG (ECX)

Categoria

Storico del prezzo dell'azione per Epigenomics AG (ECX)
Prezzo di chiusura più alto: $1.42 il 2024-06-01

Prezzo di chiusura più basso: $761.72 il 2014-09-01
Storico del prezzo dell'azione di Epigenomics AG dal 2014 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2024 -40.31%
2023 -70.25%
2022 -39.44%
2021 -83.30%
2020 -68.68%
2019 -24.83%
2018 -54.25%
2017 -3.39%
2016 90.76%
2015 -58.46%
2014 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$592.67 22.19%
US
$203.74 -3.08%
US
$23.08 67.91%
CN
$561.65 -14.11%
US
$309.55 95.37%
US